Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey.
BACKGROUND
Anemia is associated with poor outcomes in patients with aneurysmal subarachnoid hemorrhage (SAH). It remains unclear whether this association can be modified with more aggressive use of red blood cell (RBC) transfusions. The degree to which restrictive thresholds have been adopted in neurocritical care patients remains unknown.


METHODS
We performed a survey of North American academic neurointensivists, vascular neurosurgeons and multidisciplinary intensivists who regularly care for patients with SAH to determine hemoglobin (Hb) concentrations which commonly trigger a decision to initiate transfusion. We also assessed minimum and maximum acceptable Hb goals in the context of a clinical trial and how decision-making is influenced by advanced neurological monitoring, clinician characteristics and patient-specific factors.


RESULTS
The survey was sent to 531 clinicians, of whom 282 (53%) responded. In a hypothetical patient with high-grade SAH (WFNS 4), the mean Hb concentration at which clinicians administered RBCs was 8.19 g/dL (95% CI, 8.07 to 8.30 g/dL). Transfusion practices were comparatively more restrictive in patients with low-grade SAH (mean Hb 7.85 g/dL (95% CI, 7.73 to 7.97 g/dL)) (P < 0.0001) and more liberal in patients with delayed cerebral ischemia (DCI) (mean Hb 8.58 g/dL (95% CI, 8.45 to 8.72 g/dL)) (P < 0.0001). In each setting, there was a broad range of opinions. The majority of respondents expressed a willingness to study a restrictive threshold of ≤8 g/dL (92%) and a liberal goal of ≥10 g/dl (75%); in both cases, the preferred transfusion thresholds were significantly higher for patients with DCI (P < 0.0001). Neurosurgeons expressed higher minimum Hb goals than intensivists, especially for patients with high-grade SAH (β = 0.46, P = 0.003), and were more likely to administer two rather than one unit of RBCs (56% vs. 19%; P < 0.0001). Institutional use of transfusion protocols was associated with more restrictive practices. More senior clinicians preferred higher Hb goals in the context of a clinical trial. Respondents were more likely to transfuse patients with brain tissue oxygen tension values <15 mmHg and lactate-to-pyruvate ratios >40.


CONCLUSIONS
There is widespread variation in the use of RBC transfusions in SAH patients. Practices are heavily influenced by the specific dynamic clinical characteristics of patients and may be further modified by clinician specialty and seniority, the use of protocols and advanced neurological monitoring.
Department of Critical Care Medicine, Hotchkiss Brain Institute, Foothills Medical Center, University of Calgary, 1403 29th Street NW, Calgary, AB T2N 2T9, Canada. andreas.kramer@calgaryhealthregion.ca
Andreas H
AH
Kramer
Michael N
MN
Diringer
Jose I
JI
Suarez
Andrew M
AM
Naidech
Loch R
LR
Macdonald
Peter D
PD
Le Roux
D000776:Anesthesiology; D002170:Canada; D002985:Clinical Protocols; D003422:Critical Care / Q000379:methods*; D003430:Cross-Sectional Studies; D004635:Emergency Medicine; D017707:Erythrocyte Transfusion / Q000706:statistics & numerical data*; D013502:General Surgery; D019538:Health Care Surveys / Q000379:methods; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007388:Internal Medicine; D009462:Neurology; D009493:Neurosurgery; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic; D013345:Subarachnoid Hemorrhage / Q000378:metabolism / Q000628:therapy*; D011795:Surveys and Questionnaires; D014481:United States
D006454:Hemoglobins
Crit Care Med. 2005 May;33(5):1104-8
15891343
Crit Care Med. 2007 Jun;35(6):1509-16
17440420
Neurocrit Care. 2016 Feb;24(1):118-21
26195087
Radiology. 2008 Feb;246(2):543-52
18056855
Crit Care Med. 2005 Jan;33(1):189-95; discussion 255-7
15644668
Crit Care Med. 2008 Jul;36(7):2070-5
18552682
Intensive Care Med. 2009 Mar;35(3):480-8
18854976
Neurosurgery. 2010 Feb;66(2):312-8; discussion 318
20042985
J Med Internet Res. 2004 Sep 24;6(3):e30
15471756
N Engl J Med. 2007 Apr 19;356(16):1609-19
17442904
Crit Care Med. 2007 Aug;35(8):1844-51; quiz 1852
17581487
Crit Care Med. 2009 Mar;37(3):1074-8
19237920
J Neurosurg. 2008 Dec;109(6):1075-82
19035722
J Neurosurg. 2004 Mar;100(3):400-6
15035274
Crit Care Med. 1998 Sep;26(9):1576-81
9751596
Crit Care Med. 2006 Jan;34(1):196-202
16374174
JAMA. 1978 Aug 4;240(5):439-42
660888
J Cereb Blood Flow Metab. 2005 Jun;25(6):763-74
15716852
Intensive Care Med. 2009 Sep;35(9):1556-66
19533089
CMAJ. 2008 Jul 29;179(3):245-52
18663204
Health Serv Res. 2001 Feb;35(6):1347-55
11221823
Crit Care. 2009;13(3):R89
19519893
Neurosurgery. 2000 Apr;46(4):868-76; discussion 876-8
10764260
Stroke. 2009 Sep;40(9):3039-44
19628806
Neurosurgery. 2006 Oct;59(4):775-9; discussion 779-80
17038943
Neurocrit Care. 2009;10(2):157-65
19116699
Crit Care Med. 2006 Mar;34(3):617-23; quiz 624
16521258
N Engl J Med. 1999 Feb 11;340(6):409-17
9971864
Acta Neurochir (Wien). 2002 Jul;144(7):703-12; discussion 712-3
12181704
J Neurosurg. 1990 Jul;73(1):18-36
2191090